PDA’S DELAWARE VALLEY CHAPTER AND WEST PHARMACEUTICAL SERVICES, INC. ARE PROUD TO PRESENT:

The Evolving Landscape for Combination Products

Defining a Regulatory Strategy

Join the PDA and West on September 23, 2020 as they host an innovative virtual discussion featuring speakers from Amgen, J&J, CP Pathways LLC and the FDA. Industry leaders will offer insights for developing a comprehensive strategy for combination products. Learn about best practices for combination product development, regulatory requirements, risk management and control strategies, as well as, post approval device changes.

The event features presentations by:

Khaudeja Bano, Executive Medical Director, Combination Product Safety Head Global Patient Safety GRAAS, Research and Development, Amgen

Susan Neadle, Sr. Director, Global Value Chain Quality Design, Johnson & Johnson

Doug Mead, Principal Consultant and President, CP Pathways LLC

Keynote Speaker:

John Barr-Weiner, Associate Director for Policy and Product Classification Officer, FDA Office of Combination Products